Why is Valerio Therapeutics SA ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-12.99%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-12.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.24
Sales to Capital Employed (avg)
0.12
Tax Ratio
10.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.01
EV to EBIT
-1.21
EV to EBITDA
-1.49
EV to Capital Employed
6.75
EV to Sales
11.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-558.57%
ROE (Latest)
Negative BV
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Valerio Therapeutics SA
Net Profit
Higher at EUR -10.96 MM
than preceding 12 month period ended Jun 2024MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (EUR MM)
Debtors Turnover Ratio
Highest at 0.6%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
Highest at EUR 1.68 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (EUR MM)
Depreciation
At EUR 1.68 MM has Grown at 339.79%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (EUR MM)
Here's what is not working for Valerio Therapeutics SA
Operating Cash Flow
Lowest at EUR -33.43 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (EUR MM)
Cash and Eqv
Lowest at EUR 4 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 228.57 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 697,079% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






